Divergent iron-regulatory states contribute to heterogeneity in breast cancer aggressiveness
W. Leineweber, M. Z. Rowell, S. Ranamukhaarachchi, A. M. Walker, Y. Li, J. Villazon, A. M. Farrera, Z. Hu, J. Yang, L. Shi, S. I. Fraley
Abstract
Primary tumors with similar mutational profiles can progress to vastly different outcomes where transcriptional state, rather than mutational profile, predicts prognosis. A key challenge is to understand how distinct tumor cell states are induced and maintained. In triple negative breast cancer cells, invasive behaviors and aggressive transcriptional signatures linked to poor patient prognosis can emerge in response to contact with collagen type I. Herein, collagen-induced migration heterogeneity within a TNBC cell line was leveraged to identify transcriptional programs associated with invasive versus non-invasive phenotypes and implicate molecular switches. Phenotype-guided sequencing revealed that invasive cells upregulate iron uptake and utilization machinery, anapleurotic TCA cycle genes, actin polymerization promoters, and a distinct signature of Rho GTPase activity and contractility regulating genes. The non-invasive cell state is characterized by actin and iron sequestration modules along with glycolysis gene expression. These unique tumor cell states are evident in patient tumors and predict divergent outcomes for TNBC patients. Glucose tracing confirmed that non-invasive cells are more glycolytic than invasive cells, and functional studies in cell lines and PDO models demonstrated a causal relationship between phenotype and metabolic state. Mechanistically, the OXPHOS dependent invasive state resulted from transient HO-1 upregulation triggered by contact with dense collagen that reduced heme levels and mitochondrial chelatable iron levels. This induced expression of low cytoplasmic iron response genes regulated by ACO1/IRP1. Knockdown or inhibition of HO-1, ACO1/IRP1, MRCK, or OXPHOS abrogated invasion. These findings support an emerging theory that heme and iron flux serve as important regulators of TNBC aggressiveness.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cell morphology best predicts tumorigenicity and metastasis in vivo across multiple TNBC cell lines of different metastatic potential
S. J. Conner, J. R. Guarin, … M. J. Oudin·bioRxiv·Jun 14, 2023
- Molecular Plasticity of T Cells Informs Their Possible Adaptation in 4T1 Tumors
Md. Iftehimul, Robert Howard Newman, … Dipongkor Saha·bioRxiv·Oct 17, 2025
- TRIPLE-NEGATIVE BREAST CANCER CELLS RECRUIT NEUTROPHILS BY SECRETING TGF-β AND CXCR2 LIGANDS
S. SENGUPTA, L. E. Hein, … C. A. Parent·bioRxiv·Jan 28, 2021
- Metabolic dysregulations of cancer cells with metastatic potential
S. Abdul Kader, S. Dib, … A. Halama·bioRxiv·Jun 2, 2021
- HIF-1 regulated TPM3 links hypoxia to motility and invasion beyond the hypoxic fraction in triple-negative breast cancer
Chumin Zhou, Jack T. Crusher, … Ester M. Hammond·npj Breast CancerPeer-reviewed·Mar 14, 2026
- MNRR1 is required for Triple Negative Breast Cancer growth and metastasis and can be targeted by repurposed drugs.
Mrunal Sathe, Paige M. Minchella, … Siddhesh Aras·bioRxiv·Feb 3, 2026